In an effort to enhance the monitoring of persistent drug use in individuals, a group of experts hailing from the National University of Singapore (NUS) has introduced an innovative approach. Led by a professor from the NUS Department of Pharmacy, the team has uncovered three new urine biomarkers. These biomarkers could be employed to detect the consumption of the emerging synthetic cannabinoid ADB-BUTINACA, classified as a novel psychoactive substance (NPS). The same cutting-edge technology also enables the differentiation between natural and synthetic cannabinoids.
HTML PDFShare this article
Journal of Forensic Medicine received 165 citations as per Google Scholar report
